Loading...
Coloplast A/S
CLPBF•PNK
Healthcare
Medical - Instruments & Supplies
$92.59
$0.00(0.00%)
Coloplast A/S (CLPBF) Financial Performance & Income Statement Overview
Review Coloplast A/S’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
10.33%
↑ 10.33%
Operating Income Growth
8.11%
↑ 8.11%
Net Income Growth
5.62%
↑ 5.62%
Operating Cash Flow Growth
-34.55%
↓ 34.55%
Operating Margin
27.14%
↑ 27.14%
Gross Margin
67.52%
↑ 67.52%
Net Profit Margin
16.35%
↑ 16.35%
ROE
27.18%
↑ 27.18%
ROIC
19.76%
↑ 19.76%
Coloplast A/S (CLPBF) Income Statement & Financial Overview
Review Coloplast A/S's (CLPBF) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $7.03B | $6.95B | $6.88B | $6.59B |
| Cost of Revenue | $2.28B | $2.31B | $2.24B | $2.11B |
| Gross Profit | $4.75B | $4.64B | $4.65B | $4.48B |
| Gross Profit Ratio | $0.68 | $0.67 | $0.68 | $0.68 |
| R&D Expenses | $219.00M | $219.00M | $240.00M | $221.00M |
| SG&A Expenses | $2.62B | $2.58B | $2.55B | $2.48B |
| Operating Expenses | $2.84B | $2.73B | $2.79B | $2.70B |
| Total Costs & Expenses | $5.11B | $5.05B | $5.03B | $4.81B |
| Interest Income | $52.00M | $28.00M | $34.00M | $36.00M |
| Interest Expense | $220.00M | $219.00M | $237.00M | $201.00M |
| Depreciation & Amortization | $328.00M | $335.00M | $328.00M | $319.00M |
| EBITDA | $2.32B | $2.16B | $2.20B | $2.11B |
| EBITDA Ratio | $0.33 | $0.31 | $0.32 | $0.32 |
| Operating Income | $1.91B | $1.91B | $1.86B | $1.78B |
| Operating Income Ratio | $0.27 | $0.27 | $0.27 | $0.27 |
| Other Income/Expenses (Net) | -$143.00M | -$304.00M | -$226.00M | -$184.00M |
| Income Before Tax | $1.77B | $1.60B | $1.63B | $1.61B |
| Income Before Tax Ratio | $0.25 | $0.23 | $0.24 | $0.24 |
| Income Tax Expense | $725.00M | $289.00M | $357.00M | $355.00M |
| Net Income | $1.04B | $1.31B | $1.27B | $1.25B |
| Net Income Ratio | $0.15 | $0.19 | $0.19 | $0.19 |
| EPS | $4.63 | $5.84 | $5.67 | $5.57 |
| Diluted EPS | $4.63 | $5.84 | $5.67 | $5.57 |
| Weighted Avg Shares Outstanding | $225.30M | $225.00M | $224.80M | $224.70M |
| Weighted Avg Shares Outstanding (Diluted) | $225.30M | $225.00M | $224.80M | $224.70M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan